Lundin Gold Inc:企業の戦略・SWOT・財務情報

◆英語タイトル:Lundin Gold Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1739
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Lundin Gold Inc – Strategy, SWOT and Corporate Finance Report
Summary

Lundin Gold Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lundin Gold In (Lundin Gold) is a mineral exploration company. It focuses on advancement of Fruta del Norte (FDN) Project in southeast Ecuador. The FDN Project deposit is within a 150 km long copper-gold metallogenic sub-province located in the Cordillera del Condor region. The company’s properties in Ecuador comprise of 27 metallic mining concessions and three material concessions, covering an area of approximately 64,427 hectares. These concessions are operated by the company’s subsidiaries Aurelianmenor S.A., and Aurelian Ecuador S.A. (AESA). The company also focuses on drill program at the El Puma target (El Puma). El Puma is located approximately 12 km south of the Fruta del Norte Project. The company has operations in Canada and Ecuador. Lundin Gold is headquartered in Vancouver, Canada.

Scope

- Detailed information on Lundin Gold Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lundin Gold Inc in the form of a SWOT analysis
- An in-depth view of the business model of Lundin Gold Inc including a breakdown and examination of key business segments
- Intelligence on Lundin Gold Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lundin Gold Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lundin Gold Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lundin Gold Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lundin Gold Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Lundin Gold Inc: Company Overview 7
Lundin Gold Inc: Overview and Key Facts 7
Lundin Gold Inc: Overview 7
Lundin Gold Inc: Key Facts 7
Lundin Gold Inc: Key Employees 8
Lundin Gold Inc: Key Employee Biographies 9
Lundin Gold Inc: Locations and Subsidiaries 10
Lundin Gold Inc: Corporate Financial Deals Activity 11
Lundin Gold Inc: Financial Deals Overview 11
Lundin Gold Inc: Targets and Partners 13
Lundin Gold Inc: Top Deals 2014 – 2018YTD* 14
Lundin Gold Inc: Mergers and Acquisitions 15
Lundin Gold Inc: Capital Raising 16
Lundin Gold Inc: Recent Developments 17
Lundin Gold Inc: News and Events Summary 17
Lundin Gold Inc: Corporate Governance 20
Lundin Gold Inc: Financial Deals 20
Lundin Gold Inc: Financial Performance 21
Lundin Gold Inc: Strategy and Operations 21
Appendix 24
Contact Us 24
Methodology 24
About MarketLine 25

List of Tables
Table 1: Lundin Gold Inc: Key Facts
Table 2: Lundin Gold Inc: Key Employees
Table 3: Lundin Gold Inc: Locations and Subsidiaries
Table 4: Lundin Gold Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Lundin Gold Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Lundin Gold Inc: M&A Average Deal Size - Value (US$m)
Table 7: Lundin Gold Inc: Targets and Partners
Table 8: Lundin Gold Inc: Top Deals 2014 - 2018YTD*
Table 9: Lundin Gold Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Lundin Gold Inc: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Lundin Gold Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: Lundin Gold Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: Lundin Gold Inc: News and Events Summary
Table 14: Lundin Gold Inc: Corporate Governance
Table 15: Lundin Gold Inc: Financial Deals
Table 16: Lundin Gold Inc: Financial Performance
Table 17: Lundin Gold Inc: Strategy and Operations

List of Figures
Figure 1: Lundin Gold Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Lundin Gold Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Lundin Gold Inc: M&A Average Deal Size - Value (US$m)
Figure 4: Lundin Gold Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Lundin Gold Inc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Lundin Gold Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Lundin Gold Inc: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Lundin Gold Inc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Danubius Hotel And Spa Private Company Limited:企業の戦略・SWOT・財務分析
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Analytica Limited (ALT)-医療機器分野:企業M&A・提携分析
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • Galp Energia SGPS SA (GALP):企業の財務・戦略的SWOT分析
    Galp Energia SGPS SA (GALP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Athabasca Oil Corp (ATH):石油・ガス:M&Aディール及び事業提携情報
    Summary Athabasca Oil Corp (Athabasca) is an upstream energy company which focuses on exploration, development and production of bitumen, light oil and liquids-rich natural gas from oil sands and related assets. The company employs multi-stage fracturing and horizontal drilling technology from uncon …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Stantec Inc:企業のM&A・事業提携・投資動向
    Stantec Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stantec Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Capstone Therapeutics Corp (CAPS)-製薬・医療分野:企業M&A・提携分析
    Summary Capstone Therapeutics Corp (Capstone), formerly OrthoLogic Corp is a biotechnology company that develops novel peptides and other molecules. The company develops novel peptides to support patients with under-served medical conditions. It develops AZX100 and Chrysalin drug platforms. Capstone …
  • Jiangsu Jiuding New Material Co Ltd (002201):企業の戦略的SWOT分析
    Jiangsu Jiuding New Material Co Ltd (002201) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Berjaya Sports Toto Berhad:企業の戦略・SWOT・財務情報
    Berjaya Sports Toto Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Sports Toto Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lindsey Manufacturing Co:企業の戦略的SWOT分析
    Lindsey Manufacturing Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • United Therapeutics Corp (UTHR):企業の製品パイプライン分析
    Summary United Therapeutics Corp (United Therapeutics) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues includin …
  • GN Store Nord AS (GN):企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Banco BPI SA:企業の戦略・SWOT・財務分析
    Banco BPI SA - Strategy, SWOT and Corporate Finance Report Summary Banco BPI SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Monopar Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Monopar Therapeutics LLC (Monopar) is a biopharmaceutical company that develops orphan oncology compounds. The company’s pipeline product include huATN-658, a humanized monoclonal antibody for the potential treatment of various cancers including pancreatic cancer, ovarian cancer, and others. …
  • Biosynex SA (ALBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biosynex SA (Biosynex), formerly All Diag Sarl is an in-vitro diagnostic company that manufactures, research, and develops rapid diagnostic tests. The company offers rapid diagnostic kits for diagnostic applications; and designing, self-measurement, and distributing thermometers. It offers t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆